Abstract-Exercise systolic blood pressure (SBP) predicts coronary heart disease (CHD) in the general population. We tested whether changes in exercise SBP during 7 years predict CHD (including angina pectoris, nonfatal myocardial infarction, and fatal CHD) and mortality over the following 28 years. Peak SBP at 100 W workload (=5. 
S ystolic blood pressure (SBP) response to aerobic exercise has been reported to predict cardiovascular (CV) disease and mortality. [1] [2] [3] [4] [5] Exercise blood pressure (BP) may also predict future hypertension, potentially reveal masked hypertension, [6] [7] [8] [9] and improve CV disease risk stratification. 4, [10] [11] [12] [13] [14] SBP measured at low or moderate exercise intensity seems to be more closely associated with future risk of CV disease and mortality than SBP measured at maximum effort. 1, 3, 4, 10 We have previously shown that exercise SBP at 100 W workload (=5.5 METS [metabolic equivalents]) (SBP100W) predicts coronary heart disease (CHD) death and CV death. 2, 3 Moreover, we have previously studied predictors of 7-year changes in SBP100W (∆SBP100W). 15 However, the prognostic impact of temporal changes in exercise BP on risk of CV disease and mortality has not been studied before.
The main aim of the present work was to study the possible association between ∆SBP100W and future CHD among 1392 apparently healthy men. Second, we studied the possible association between ∆SBP100W and future CHD death, CV death, and all-cause death. Third, we studied the impact of ∆SBP100W on the abovementioned end points among a subgroup of 691 normotensive men (resting BP <140/90 mm Hg both at the first and second surveys). Finally, we assessed the possible impact of physical fitness (PF) and 7-year change in PF (∆PF) on these possible associations.
Methods

Study Population
The present study included a subpopulation of 1392 men in the Oslo Ischemia Study who fulfilled our criteria for studying the possible prognostic impact of ∆SBP100W on CHD (Figure) . The Oslo Ischemia Study consists of 2014 apparently healthy men aged 40 to 59 years recruited from 5 governmental institutions in Oslo during the years 1972-75. 16 All men gave their informed consent before inclusion. Further details about selection procedures and exclusion criteria have been presented elsewhere, 3, 16, 17 and are further described in the onlineonly Data Supplement. All participants underwent standardized clinical examinations, blood tests, chest x-ray, resting ECG, and symptomlimited bicycle exercise ECG test at inclusion (survey 1, and identical examination in the years 1979-82 (survey 2). The family history of CHD (angina pectoris, nonfatal/fatal myocardial infarctions among parents or siblings) was registered in questionnaires. To be included in the present study, the men had to remain healthy at survey 2, and having completed a workload of 100 W at both survey 1 and 2.
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Examinations
All men performed a standardized bicycle exercise ECG-test and were examined by the same physician (J.E.) at both surveys. The initial workload was 6 minutes on 100 W, increased by 50 W every 6 minutes, and the men were encouraged to continue exercise until exhaustion or until exhibiting signs or symptoms causing an early test termination. 18 SBP was measured to the nearest 5 mm Hg every second minute throughout the test. Peak SBP at 100 W, defined as SBP100W, was the last recording on 100 W workload. PF was defined as the total bicycle exercise work (Joule), calculated as the sum of work at all workloads divided by body weight (kg). Further details about BP measurements are given in the online-only Data Supplement and have also been presented previously. 3, 19 Follow-Up 
End Points
The main end point in the present study, CHD, was composite: either angina pectoris, nonfatal myocardial infarction, and CHD death. The secondary end points were CHD death, CV death, and all-cause death. Angina pectoris was defined by having typical angina symptoms and documented use of nitroglycerin. Most men with angina also had objective signs of exercise-induced ischemia detected at follow-up examinations. In the present study, CV events are confined to angina pectoris, nonfatal hospital-verified acute myocardial infarction, aortic abdominal aneurysms, peripheral artery disease, strokes (hemorrhagic or embolic), and pulmonary embolism. Acute myocardial infarction and strokes diagnosed in conjunction with major surgery were not included. Interval between CV events had to exceed 6 months to count as separate events. Only the first event from a specific disease was counted. CV death includes sudden death, myocardial infarction, stroke (cerebral infarction and hemorrhage), and pulmonary embolism.
Statistical Methods
Kendall rank test was used to assess correlation (trend) between ∆SBP100W-quartiles and characteristics of participants. The risks of end points in ∆SBP100W-quartiles were estimated by KaplanMeier plots and tested with log-rank tests. Cox proportional-hazard modeling was used when calculating hazard ratios. Significant variables in univariable analyses (P<0.05) were entered into multivariable analysis, and a final prediction model was reached by stepwise backward variable selection. SBP100W and PF canceled each other out and both became borderline-significant when entered together into the multivariable model. We chose to keep SBP100W in the main multivariable prediction model because it forms the baseline level for ∆SBP100W (Table 2) . A succession of adjusted survival models were examined: first, for survey 1 age and SBP100W; second, for the conventional CV risk factors (family history of CHD, smoking, total cholesterol, and resting SBP) at survey 1 in addition to age and SBP100W (model 1); and finally, a maximally adjusted model that included survey 1 PF and ∆PF in addition to model 1 (model 2). The same adjustment models were used for all end points to get comparable relative risk estimation. Additional analyses of subgroups and sensitivity analyses of other potential predictors of CHD were also performed; see Results section. The ∆SBP100W-quartile limits from the total material were used also for the group of 691 normotensive men.
Results
Characteristics of Participants
At survey 1, the 1392 men were in average 49.2 years, had a body mass index of 24.4, and 546 men (39.2%) were current smokers. Mean resting SBP was 127.3 mm Hg, and mean SBP100W was 177.3 mm Hg. Mean SBP increased with 3.4 mm Hg, and SBP100W increased with 3.0 mm Hg from survey 1 to survey 2. Age and percentage of smokers at survey 1, time between surveys and change in resting SBP, body mass index, maximal SBP, and diastolic BP were correlated with increasing ∆SBP100W, whereas survey 1 SBP100W, maximal SBP, PF, and ∆PF were inversely correlated with ∆SBP100W. Body mass index showed a trend toward inverse correlation across quartiles (Table 1) . Measurements and characteristics among 691 normotensive men showed similar correlations between categories of ∆SBP100W (Table S1 ).
Predictors of CHD
∆SBP100W was a significant predictor of CHD both in univariable and multivariable analyses. All other significant, independent variables of CHD were included in the multivariable analysis depicted in Table 2 . PF was borderline-significant when additionally included. Predictors of CHD among the 691 normotensive men were almost identical to predictors among all 1392 (Table S2) .
Additional analyses showed that ∆SBP100W was a significant predictor of CHD death, CV death, and all-cause death in both univariable and multivariable analyses (data not shown).
End Points
Crude incidence of CHD among the 1392 men was 452 (32.5%) during up to 27.7 years (median, 20.8) comprising 25 280 person-years of follow-up until death or end of observation period after survey 2. The incidence of CHD, CHD death, CV death, and all-cause death increased with increasing ∆SBP100W-quartiles (Tables 3 and 4 ).
Relative Risks of CHD
Risks of CHD increased with increasing ∆SBP100W-quartiles as shown in the Figure. The highest ∆SBP100W-quartile (Q4) had a 55% increased risk of CHD, when adjusted according to model 1 compared with the lowest quartile (Q1), and a 31% increased risk compared with Q2. When applying model 2 (adjustments including PF and ∆PF), Q4 was still associated with a 40% increased risk of CHD compared with Q1, but there was only a trend (P=0.06) toward increased risk compared with the second lowest quartile (Table 3 ). The second highest quartile (Q3) was associated with a 31% increased risk compared with Q1 when model 1 adjustments were performed, but not with significantly increased risk when also adjusting for PF and ∆PF (Table 3) .
When analyzing risks of angina pectoris, nonfatal myocardial infarction, and CHD death separately, only CHD death remained independently associated with ∆SBP100W-quartiles ( Table 4 and Table S3 ).
Relative Risks of Death
Q4 was associated with increased risk of death from CHD, CV, and all-cause compared with Q1 when applying model 1 adjustments. When further adjusting according to model 2, only risk of CHD death remained significantly increased in Q4 compared with Q1. However, a trend (P=0.08) toward higher risk of CV death in Q4 compared with Q1 remained also when adjusted according to model 2 (Table 4) .
Relative Risks of CV End Points Among Normotensive Men
In the subgroup of 691 normotensive men, the incidence of CHD was 199 (28.8%). The highest ∆SBP100W-category was associated with a significantly increased model 1 adjusted risk of CHD death, CV death, and all-cause death; hazard ratios 1.77 (1.13-2.76), 2.15 (1.19-3.84), and 1.48 (1.03-2.11) compared with the lowest category, respectively. The highest category of ∆SBP100W was associated with a borderline-significant 2.09-fold (0.99-4.31; P=0.0520) increased risk of CHD death. When further adjusted according to model 2, ∆SBP100W-categories were not associated with risk of CV end points (details elaborated in online-only Data Supplement).
Sensitivity Analyses
Several other possible predictors of CHD, including fasting blood glucose, serum creatinine, high-density lipoprotein, ∆Resting heart rate (SD) 0.9 (11.7) 2.4 (11.1) 1.6 (12.0) 3.6 (9.8) 0.0001
Values are mean (SD) or numbers, n (%). Family history of CHD, certain history of CHD (angina pectoris, nonfatal myocardial infarction, or coronary heart death) among parents or siblings; ∆, change (difference) between surveys 1 and 2; physical fitness, total work performed during bicycle exercise test (kJ) divided by body weight (kg); P value, P value for trend calculated by Kendall rank test. BP indicates blood pressure; DBP, diastolic blood pressure; NA, not applicable; maximal SBP, peak SBP measured during bicycle exercise test; ns, not significant; SBP, systolic blood pressure; and SBP100W, SBP at 100 W workload on bicycle exercise test.
*Measured at survey 1 only. by guest on April 13, 2017 http://hyper.ahajournals.org/
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maximal heart rate at exercise, heart rate recovery, signs of left ventricular hypertrophy on ECG (Minnesota code), ST-segment changes during exercise, a forced expiratory volume at first second, and perceived daily stress levels, were introduced into the multivariable analysis in addition to model 1 and 2 adjustments to evaluate potential impact on results. Including high-density lipoprotein (measured at survey 2 only among 1326/1392 men) into the analysis strengthened results n indicates number of men; CHD, coronary heart disease, composite end point of angina pectoris, nonfatal myocardial infarction, and death from coronary heart disease; end points given as crude incidence (%); relative risks are given in hazard ratios (95% confidence interval) compared with the quartile used as reference; SBP100W, systolic blood pressure measured at 100 W workload; model 1, adjusted for survey 1 age, smoking status, total cholesterol, resting systolic blood pressure, SBP100W, and family history of CHD; model 2, adjusted for survey 1 physical fitness and change (∆) in physical fitness in addition to model 1; physical fitness, total work performed during bicycle exercise test (kJ) divided by body weight (kg); ∆ PF, change in physical fitness between surveys 1 and 2 (difference).
*P=0.06. Hazard ratio per 1 SD increase in parameter (parameter units as in Table 1 ). Possible predictors are measured at survey 1 except Δ which indicates change (difference) between survey 1 and 2; family history of CHD, certain history of CHD (angina pectoris, nonfatal myocardial infarction or coronary heart death) among parents or siblings; physical fitness, total work performed during bicycle exercise test (kJ) divided by body weight (kg); SBP100W, SBP at 100W workload on bicycle exercise test; maximal SBP, peak SBP measured during bicycle exercise test. CHD indicates coronary heart disease; CI, confidence interval; DBP, diastolic blood pressure; HR, hazard ratio; and SBP, systolic blood pressure.
*Correlated with SBP, not significant when entered into the multivariable analysis with SBP. †Inversely correlated with SBP100 at survey 1 and cancel each other out in multivariable analysis. by guest on April 13, 2017 http://hyper.ahajournals.org/
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May 2013 marginally (detailed data not shown), whereas other variables did not change results.
Discussion
We investigated the possible association between ∆SBP100W over 7 years and long-term risk of CHD and death among 1392 apparently healthy middle-aged men followed for more than 25 000 person-years. We found that ∆SBP100W was a significant predictor of CHD, CHD death, CV death, and allcause death when adjusted for classical CV risk factors, but that adjustments for PF and ∆PF had significant impact of the results, abolishing the association between all-cause death risk and ∆SBP100W. In line with previous studies, we confirmed that SBP100W was a significant predictor of death from CHD and CV. We also found that ∆SBP100W was an independent predictor of CHD, CV death, and all-cause death among healthy normotensive men when adjusting for SBP100W and conventional CV risk factors.
Determinants of Change in Exercise BP
As previously reported, age, SBP at rest, SBP100W, smoking status, body mass index, PF, and forced expiratory volume predicted ∆SBP100W. 15 Also as reported previously and as shown in Table 1 , SBP100W at survey 1 was correlated inversely with ∆SBP100W. Because none of these men were treated with BP-lowering drugs between the 2 surveys, this relation may be partially explained by regression to the mean, although lifestyle changes cannot be excluded. The more favorable ∆PF in the lowest ∆SBP100W-quartile may reflect a change toward a healthier lifestyle. On the other hand, more men stopped smoking in the highest ∆SBP100W-quartile than the lowest ∆SBP100W-quartile. Regression to the mean will probably underestimate the prognostic impact of ∆SBP100W, and the strength of the association between ∆SBP100W and CV risk may therefore have been underestimated in the present study.
Comparisons With Relevant Literature
Because the present study is the first to assess risk association between temporal changes in exercise BP and CV end points, no direct comparison of results can be made. Our results add further support to the hypothesis that there is a consistent, graded, and independent association between SBP measured at low-to-moderate exercise intensity and CV risk. Previous research on exercise BP among apparently healthy individuals have mainly focused on CV mortality, although some studies also have found an association between exercise BP and myocardial infarction. [2] [3] [4] [5] 20 Our findings extend previous knowledge because we demonstrate that changes in exercise BP also predict CHD and death. These findings may be important because they pave the way for further research using exercise BP, for example, for assessing risk modification over time.
Exercise BPs are difficult to compare between studies because of differences in type of exercise test, protocols, and exercise intensity at which BP recordings are made. SBP100W at survey 1 was only marginally higher in the present study than that measured at 80 W workload by Laukkanen et al 20 (mean, 173.7 mm Hg), but clearly lower than that measured at 164 W workload by Filipovsky (mean, 195.9 mm Hg). 5 Resting SBP and proportion of men with BP >140/90 mm Hg at inclusion were in similar range as other studies on exercise BP and CV risk when age at inclusion is taken into account. 
PF and Potential Pathophysiological Mechanisms
Physical activity and PF, and changes in the two show inverse associations with CV risk factors and risk markers, and also with CHD, CV death, and all-cause mortality. 10, 14, 17, 22 PF is usually defined as maximal aerobic capacity, and maximal oxygen uptake (V0 2max ) is considered to be the gold standard for assessing PF. Our method of measuring PF has shown a n indicates number of men; end points given as crude incidence (%); CHD, death from coronary heart disease; CV death, death from CHD, stroke, pulmonary embolism, sudden death, or aortic disease; relative risks are given in hazard ratios (95% confidence interval) compared with the quartile used as reference; model 1, adjusted for survey 1 age, smoking status, total cholesterol, resting systolic blood pressure, peak systolic blood pressure at 100 W workload, and family history of CHD; model 2, adjusted for survey 1 physical fitness and change (Δ) in physical fitness in addition to model 1; physical fitness, total work performed during bicycle exercise test (kJ) divided by body weight (kg); Δ PF, change in physical fitness between surveys 1 and 2 (difference). CV indicates cardiovascular. *P=0.08.
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very high correlation with VO 2max. 23 Adjustments for PF and ∆PF attenuate the association between ∆SBP100W and disease risk in the present study. Point measures and changes in BPs at rest and exercise are mutually correlated and inversely correlated with PF and ∆PF, and may therefore convey some of the same physiological information. Thus, adjusting for PF and ∆PF may represent an overadjustment of results that conceals the prognostic information of change in exercise BP. On the other hand, it is possible that high PF and positive ∆PF may modify the increased risk associated with an increase in SBP100W through improving CV risk factors not accounted for in the present study, for example, changes in endothelial properties. 14, 24 Measurements of PF require exercise until exhaustion or near exhaustion, often resulting in time-consuming tests and potentially poor patient compliance. Several studies have shown that SBP at low-to-moderate exercise load is more closely associated with future CV risk than SBP measured at submaximal or maximal exercise intensity. [2] [3] [4] [5] Furthermore, adaptability to physiological stress may be better revealed by starting directly at moderate exercise load than by starting at low intensity with gradual increase in workload.
5 SBP100W seems to convey much of the same prognostic information on CV risk as PF and can easily be measured during short bouts of physical exercise.
Strengths
The present study is prospective in design, and all data sets are virtually complete. We have no work-up bias, and all event data are on the basis of complete hospital records and causespecific death records. All men were healthy and free of drugs until survey 2, and the study group has not interfered with treatment in case of disease. Thus, temporal changes in BP should reflect spontaneous changes, except alterations that might be imposed by lifestyle interventions.
Limitations
Our cohort consists of middle-aged white men who were healthy and full-time employed at inclusion. Therefore, our findings cannot necessarily be generalized to individuals of other age, ethnicity, sex, or in the setting of significant morbidity and chronic drug use.
Perspectives
Our findings indicate that ∆SBP100W adds prognostic information beyond classical risk factors on risk of CHD death among healthy middle-aged men. This supports previous findings, suggesting that SBP at low-to-moderate exercise intensity correlates with total peripheral resistance, which in turn is associated with underlying vascular properties. 13, 14, 24 Furthermore, exercise BP has the potential to reveal masked hypertension. 8, 9 Future research should compare point estimates and serial measurements of exercise and ambulatory BP both in terms of predictive ability for CV risk and cost-effectiveness.
Conclusions
The present study indicates that an increase in exercise SBP at 100 W over 7 years is independently associated with significantly increased long-term risk of CHD, CHD death, CV death, and all-cause death. However, these associations are attenuated to some degree by PF and temporal change in PF. Our findings substantiate that high-exercise SBP is a strong CV risk factor in healthy men.
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Methods
Study population
Men aged 40-59 years working in five Governmental agencies in Oslo, Norway, were recruited for a cardiovascular health survey which took place between August 28, 1972 and March 21, 1975 . Only employees working in agencies practicing annual or biennial health examinations of all their employees were chosen for the study. Eligibility of each man was decided after joint scrutiny of his health records by the Chief Medical Officer of each agency and the survey leader (JE). Presence of any of the following diseases caused primary exclusion: Known or suspected coronary heart disease, diagnosed hypertension requiring drug treatment, diabetes mellitus, thyroid disorders, cancer, advanced pulmonary, renal, or liver diseases, or other serious disorders. Subjects on any chronic drug regimen were also excluded, as were those who for various reasons were judged unable to conduct a symptom limited bicycle exercise ECG test properly (e.g. for orthopedic, neurological, or muscular reasons). In all 2341 men fulfilled these health criteria and 2014 (86%) agreed to participate.
Men who at arrival for the study reported that any of the above mentioned diseases/disorders had been diagnosed elsewhere after their last visit to the company health office, underwent a full survey examination, but were later excluded from our files. Accordingly our study population was judged to represent a group of apparently healthy men aged 40-59 years.
Examinations
The men answered an extensive questionnaire including queries on family history, former diseases and use of drugs. The examinations took place in the morning hours and all men had been requested to abstain from smoking for at least 8 hours and from eating for 12 hours. Clinical parameters were examined under standardized conditions after 5 minutes rest in a supine position in a quiet room. Blood for cholesterol measurements and other blood tests was drawn before the exercise test and analyzed by standard methods. HDL-cholesterol was measured in 1326 of the 1392 men, at Survey 2 only.
Blood pressure measurements
The fifth phase of Korotkoff sounds established diastolic BP. BP was measured three times, where the first measurement approximately established the pressure level. The second measurement was a very careful procedure with first elevating the arm for venous draining, and then lowering the arm with measurements during inspiration followed by relaxed expiration. The third measurement was identical to the second. There was a systematic minimal fall in BP from the first to the second reading, and then on average a minimal rise in BP (<1 mm Hg) from the second to the third reading. The second reading was therefore considered the most basic recording, and has therefore been used as baseline value.
Bicycle exercise ECG-tests
Exercise ECG-tests were performed using an electrically braked Elema bicycle. The initial workload was set at 100W and increased by 50W every 6th minute. The starting load was selected as 100W because it was judged that apparently healthy, middle-aged Norwegian men would be able to cycle at this workload for at least 6 minutes. The decision was based on a pre-survey of 80 men of whom all completed 6 minutes at the 100W workload. All subjects were encouraged to continue until exhaustion. The test was, however, terminated for safety reasons if a subject stated that he felt unable to continue the test, even without communicating specific reasons. The exercise tests were also terminated for the following pre-specified reasons: major cardiac arrhythmias, drop in systolic blood pressure of ≥ 10 mmHg on two successive measurements one minute apart, atrioventricular block, ST-depressions > 3 mm, severe dyspnoea or increasing chest pain. At the first examination in 1972-75, 1999 out of the 2014 men completed the 100W workload, while 1392 of the men who were still healthy at the second examination 1979-82 completed the 100W workload.
Reproducibility of exercise test measurements was tested by repeating the test within two weeks in a random sub set of 130 of the 2014 participants at the first survey in 1972-75. Blood pressures, heart rates and working capacity at the two tests were within ± 5% in 90% of the men and within ±10% in all of them, indicating excellent reproducibility.
Measurements of blood pressure during exercise
Systolic blood pressure was measured every second minute throughout the exercise test, and more often if fall in blood pressure was suspected. The peak systolic blood pressure at each workload was recorded and used for further scrutiny. Peak systolic blood pressure on the 100W workload (SBP100W) was the third recording for almost all men, and this value is used for studying the prognostic impact of exercise blood pressure at 100W in the present study. The maximal systolic blood pressure prior to stopping the exercise test was also recorded; this was the final measurement just before termination of exercise for almost all men.
Endpoints and follow-up
The men were re-examined at three surveys after inclusion 1972-75, and two nationwide searches of patient records in Norwegian hospitals were also performed as shown in flowchart (Figure online supplement) . The last follow-up of the cohort was initiated in 2005 and finished on the 31 st of December 2008. With permissions from all relevant authorities, all 2014 subjects in the cohort were linked with patient journals using their Norwegian social security number. Hospital records were manually scrutinized on site, and data were obtained from all available sections in records, e.g. outpatient notes, general practitioners' letters, autopsy reports, ECG-readings, surgery notes, admission and discharge letters. We obtained complete update of causespecific deaths from Statistics Norway, that keep national records of all deaths within Norway.
Angina pectoris was also diagnosed when the hospital files revealed the written diagnosis of angina in combination with documented use of short or long acting nitrates. Most men diagnosed with angina pectoris had, however, exercise induced ischemia. Since the diagnosis of angina pectoris was not confined to men with objective evidence of myocardial ischemia, misdiagnosis cannot be ruled out. However, 70 (42%) of the 168 men with angina pectoris as the first or only manifestation of CHD in the present study went through coronary revascularization later on, as opposed to 65 (5%) of the other 1224 men in the present study. Thus, the diagnostic performance of angina pectoris in this study appears to be sufficient despite some limitations. Table S1 Relative risks of angina pectoris and acute non-fatal myocardial infarction in quartiles of seven-year change in exercise systolic blood pressure at 100W (n=1392) n = number of men, crude incidence of angina pectoris (%) and non fatal myocardial infarction (%) in bold , hazard ratios (95% confidence interval) compared to the quartile used as reference, model 1: adjusted for Survey 1 age, smoking status, total cholesterol, resting systolic blood pressure, peak systolic blood pressure at 100W exercise and family history of CHD; model 2: adjusted for physical fitness at Survey 1 and change (∆) in physical fitness between Survey 1 and 2 in addition to model 1, physical fitness: total work performed during bicycle exercise test Hazard ratio per 1 Standard deviation (SD) increase in parameter (parameter units as in table 1 and SD for all 1392 men in the present study).
Predictors are measured at Survey 1 except ∆, change (difference) between Survey 1 and 2; Family history of CHD, certain history of CHD (angina pectoris, non-fatal myocardial infarction or coronary heart death) among parents or siblings; DBP, diastolic blood pressure; physical fitness, total work performed during bicycle exercise test (kJ) divided by body weight (kg); SBP, systolic blood pressure; SBP100W, SBP at 100W workload on bicycle exercise test; maximal SBP, SBP measured at highest workload achieved on bicycle exercise test; * correlated with SBP, not significant when entered into the multivariable analysis with SBP; † Inversely correlated with SBP100 at Survey 1 and cancel each other out in multivariable analysis. n indicates number of men in each category; crude incidence (%) of endpoints in bold; CHD, coronary heart disease, composite endpoint of angina pectoris, non-fatal myocardial infarction and death from coronary heart disease; CHD death, death from coronary heart disease; CV death, death from CHD, stroke, pulmonary embolism, sudden death or aortic disease; relative risks are given in hazard ratios (95% confidence interval) compared to quartile 1; SBP100W, systolic blood pressure measured at 100W workload; model 1, adjusted for Survey 1 age, smoking status, total cholesterol, resting systolic blood pressure, SBP100W and family history of CHD; model 2, adjusted for Survey 1 physical fitness and change (∆) in physical fitness in addition to model 1; physical fitness, total work performed during bicycle exercise test (kJ) divided by body weight (kg); ∆ PF: change in physical fitness between Survey 1 and 2 (difference), * p = 0.0520.
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Legend, Figure S1 Flow chart showing the total Oslo Ischemia Study cohort (left side) and the present study including 1392 men (right side) during 28 years follow up after Survey 2
